Objective: Determining the effects on macular ganglion cell layer thickness in patients using isotretinoin by utilization of optical coherence tomography.
Introduction :
Isotretinoin is a synthetic retinoid used for various dermatological diseases such as severe nodular cystic acne, acne vulgaris, stubborn psoriasis and is frequently used for various types of cancers. [1] Isotretinoin has many known systemic and ocular side effects. The ocular side effects of isotretinoin are; meibomian gland atrophy, impaired meibomian gland secretion, blepharoconjunctivitis, dry eye, keratitis, myopia, decreased dark adaptation, decreased color vision, permanent dark adaptation, optic neuritis, diplopia, optic disc edema and intracranial hypertension. [2, 3] Retinal ganglion cells contain melanopsin.
Melanopsin is very similar to other opsin photopigments and is a retinaldehyde chromophore. Isotretinoin has an inhibiting effect on the chromophore regeneration of retinal ganglion cells. [4] In this study, the effects on retinal ganglion cell layer thickness in patients using oral isotretinoin was investigated. The macular ganglion cell layer was measured at the thickest part of the macula, whereas the retinal nerve fiber layer thickness was measured from the temporal peripapillary area.
Methods:

Statistical Analysis:
The statistical analysis were performed using the 
Results:
The mean duration of the isotretinoin treatment was 3.5±2.1 months. The average age of the patients using isotretinoin was; 21.2 ± 3.62 years, whereas the average age of the patients in the control group was 22.7 ± 3.7 years. Demographic data study group in table 1. No statistically significant difference related to age was observed in the macular ganglion cell layer thickness in between the control group and the patients using isotretinoin in Table 2 (p>0.05). No statistically significant difference was observed in the thickness of the macular ganglion cell layer, the retinal nerve fiber layer and macular thickness of the left or right eye between the control group and the patients using isotretinoin(p>0.05).
In Table 3 , no statistically significant difference was observed between the right or left eye regarding the thickness of the macular ganglion cell layer, the retinal nerve fiber layer and macular thickness in the group using isotretinoin (p>0.05). No statistically significant difference was observed between the right or left eye regarding the thickness of the macular ganglion cell layer, the retinal nerve fiber layer and macular thickness in the control group(p>0.05). In Table 4 , a statistically significant, moderate degree, negative 
Discussion:
It is considered that retinoids play a vital role in the function, replacement,and growth of the nerve field of vision defects due to optic neuropathy and / or psodotumorcerebri are more common. [9] Several studies have reported the importance of determining the RNFL thickness for the management and early diagnosis of glaucoma, optic nerve diseases and optic nerve disorders containing optic neuritis. [10] OCT defines the changes in the RNFL thickness before the emergence of defects of the visual field. [11] Dinc et al [12] reported cases of decreased RNFL thickness and bilateral optical disc atrophy related to isotretinoin administration for the treatment of acne vulgaris. Ucak et al. [13] reported the possible toxic effects of isotretinoinon RNFL, especially in the temporal layer. In the study conducted by Kapti et al. [14] It is reported that isotretinoin has no effect on RNFL thickness We did not find a statistically significant difference in RNFL thickness in our study. Sari et al. [9] investigated the optical nerve function, both clinically and in vision field test in patients treated with oral tretinoin and have not observed any differences in the same findings during 5.5 months. Sekeryapan et al. [15] did not find any difference in the thickness of GCL in patients using systemic isotretinoin in their study. We were unable to find any statistically significant difference in the GCL thickness in our study as well. Demirok et al. [16] found no significant effect on macular ganglion cell layer thickness in patients who used systemic isotretinoin for 1 year.
As a result, even though oral isotretinoin has different ocular side effects, no effects related to the thickness of the retinal nerve fiber and the ganglion cell layer could be observed.
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